CMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of ...

In "Closing Reflections on the Future of Vitiligo Care," each panelist shares closing reflections on where vitiligo care is ...

Weekly survodutide 3.6 mg/6.0 mg achieved up to 13.1% mean weight loss at week 76 versus 3.1% with placebo, meeting ...

AASM urges CMS to reject proposed 2027 Medicare conversion factor cuts of 1.19% to 1.68% and revise sleep testing and remote ...

NHANES 1999–2018 CKD adults (n=3965) showed 1163 deaths; RAR quartiles ranged from <2.93 to ≥3.45, enabling population-level ...

Weighted average monthly Medicare Advantage (MA) premiums are projected to fall 16.5% in 2027, while average premiums for ...

At the Community Oncology Alliance Payer Exchange & Innovation Summit in September, a panel of statistical experts posed a ...

Any weekend catch-up sleep was independently associated with lower OAB odds (adjusted OR 0.79; 95% CI 0.67–0.93) after ...

Once-weekly retatrutide reduced body weight by an average of 20.8% at the highest dose and lowered hemoglobin A 1C (HbA 1C) ...

FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, ...

A rare case of soft-tissue sarcoma spreading to the heart shows how multimodal imaging guided diagnosis and care in a 36-year ...

Open-source oncology tools span patient-facing trackers and explainers, genomics-to-therapy ranking systems, and LLMs ...